Starling Oncology, Inc.
STLN · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Mar 2026
Open the dashboardInfographicSummary
FY2025 key figures
| $ | FY2025 | FY2024 | Change |
|---|---|---|---|
| Revenue | $503M | $393M | +27.8% |
| Operating income | −$36.1M | −$60.1M | +40.0% |
| Net income | −$50.3M | −$53.0M | +5.1% |
Questions
- What was Starling Oncology's revenue in FY2025?
- $503M in FY2025 (Fiscal year ended Dec 31, 2025), +27.8% vs $393M a year earlier, per its 10-K filed Mar 2026.
- Was Starling Oncology profitable in FY2025?
- No: net income was −$50.3M and operating income −$36.1M in FY2025.